2022-2029 年全球结核病检测市场

市场动态

结核病检测市场受到结核病和耐多药结核病负担增加、政府举措增加以及新兴市场意识提高的推动。

预计日益增加的结核病负担将推动市场增长。

感染冠状病毒的人数和肺结核患者人数的增加将推动市场。据世界卫生组织 (WHO) 估计，2020 年全球将有 1000 万人死于结核病，其中包括 560 万男性、330 万女性和 110 万儿童，占全球结核病死亡人数的一半。推动市场增长的因素包括结核病和耐多药结核病负担的增加、研发投资的增加、产品线的扩大以及新兴市场的政府举措增加。在过去十年中，结核病诊断领域发生了巨大变化。此外，为了响应世卫组织的全球结核病规划，它实施了一个系统和动态的过程，用于评估技术和製定政策以推动市场增长。

此外，结核病的患病率逐年增加，预计将在预测期内推动市场以及影响人们选择诊断测试（例如 X 射线检查）的政府宣传计划的数量。随着市场上存在促进基础结核病研究和加速管道诊断市场批准的机会，预计市场也将增长。此外，诊断提供商可以利用基因组学和蛋白□□质组学的技术发展来促进结核病诊断产品的开发。

提高高负担地区的筛查率、降低诊断试剂的成本、先进的研究方法、快速的临床决策和降低死亡率是发展的重点。这些努力的结果是预防/治疗诊断率的提高。因此，对诊断测试的需求增加，结核病诊断药物市场被激活。此外，政府和独立医疗机构正在努力遏制这种传染病的传播。提高对诊断重要性的认识对于提高筛查和诊断率至关重要，有助于进一步繁荣结核病诊断市场。这些因素正在推动预测期内的市场增长。例如，印度修订的国家结核病控制计划 (RNTCP) 侧重于通过免费诊断和治疗计划进行结核病筛查和改善获得治疗的机会。该计划的公私合作伙伴关係也提高了诊断率。

60 岁及以上的人群是结核病诊断市场的目标人群，因为他们更容易感染传染病。因此，不断增长的老年人口正在推动市场的增长。

结核病药物引起的耐药性预计将阻碍市场增长。

然而，结核病耐药性是医护人员最关心的问题之一。由于错误的药物方案和不适当的剂型导致治疗不充分，导致接受治疗的肺结核患者产生耐药性，抑制了市场增长。

行业分析

全球结核病检测市场根据波特五力、监管分析、供应链分析、定价分析、产品创新和未满足的需求等各种行业因素对市场进行了深入分析。

全球结核病检测市场报告包含大约 45 多个市场数据表、40 多个数字和 180 页。

内容

第 1 章全球结核病检测市场研究方法和范围

• 调查方法
• 调查目的和范围

第 2 章全球结核病检测市场 - 市场定义和概述

第 3 章全球结核病检测市场 - 执行摘要

• 按测试类型划分的市场细分
• 最终用户的市场细分
• 按地区划分的市场细分

第 4 章全球结核病检测市场动态

• 市场影响因素
  • 驱动程序
    • 结核病和耐多药结核病的负担日益加重
    • 新兴市场的政府努力和日益增强的意识
  • 限制因素
    • 肺结核诊断费用高
    • 抗结核药物
• 影响分析
• 机会

第 5 章全球结核病检测市场 - 行业分析

• 波特五力分析
• 供应链分析
• 监管分析
• 定价分析
• 产品分析
• 工业价值链分析

第 6 章全球结核病检测市场 - 按检测类型

• 核酸肌鬆
• 细胞因子检测法
• 检测潜伏感染
• 培养肌样试验
• 药物敏感肌生长抑制素
• 其他

第 7 章。全球结核病检测市场 - 按最终用户分类

• 医院检查室
• 研究所
• 诊所检查室
• 诊断中心

第 8 章。全球结核病检测市场 - 按地区划分

• 北美
  • 美国
  • 加拿大
  • 墨西哥
• 欧洲
  • 德国
  • 英国
  • 法国
  • 其他欧洲
• 南美洲
  • 巴西
  • 阿根廷
  • 其他南美洲
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 其他亚太地区
• 中东和非洲

第 9 章。全球结核病检测市场的竞争格局

• 竞争场景
• 市场情况/份额分析
• 併购分析

第 10 章全球结核病检测市场公司简介

• Thermo Fisher Scientific, Inc.
  • 公司概况
  • 产品组合和描述
  • 主要发展状况
  • 财务摘要
• Hologic Corporation
• Abbott Laboratories
• Alere, Inc.
• Lupin Pharmaceuticals, Inc.
• Becton, Dickinson and Company
• F. Hoffmann-La Roche AG
• bioMerieux SA
• Sanofi.
• Cepheid
• List is not exhaustive

第 11 章全球结核病检测市场 - 主要考虑因素

第 12 章全球结核病检测市场数据M

Market Overview

The Tuberculosis Testing Market size was valued at US$ 1,337.10 million in 2021 and is estimated to reach US$ 2058.0 million by 2029, growing at a CAGR of 6.0% during the forecast period (2022-2029).

Tuberculosis (TB) is a communicable disease that is a major cause of ill health, one of the top 10 causes of death worldwide, and the leading cause of death from a single infectious agent. It is caused by the bacillus Mycobacterium tuberculosis, which is spread when sick people with TB expel bacteria into the air, for example, by coughing. It typically affects the lungs (pulmonary TB) but can also affect other sites. About a quarter of the world's population is infected with M. tuberculosis and thus at risk of developing TB disease. Tuberculosis testing can be defined as the most commonly used diagnostic tool for tuberculosis. With a timely diagnosis and treatment with first-line antibiotics for 6 months, most people who develop TB can be cured, and onward transmission of infection curtailed. The number of TB cases occurring each year can also be driven down by reducing the prevalence of health-related risk factors for TB providing preventive treatment to people.

Market Dynamics

The tuberculosis testing market is driven by the increasing burden of tuberculosis and multidrug-resistant tuberculosis, increasing government initiatives and rising awareness in the emerging market.

Increasing burden of tuberculosis are expected to drive market growth.

The market is driven by the increasing number of coronavirus cases, increasing the number of tuberculosis patients. According to the World Health Organization (WHO), in 2020, an estimated 10 million people fell ill with tuberculosis (TB) worldwide, 5.6 million men, 3.3 million women and 1.1 million children, which is more than half of global TB deaths. Factors propelling the market's growth include the increasing burden of tuberculosis and multidrug-resistant tuberculosis, increasing R&D investments, intensive product pipelines, and increasing government initiatives in the emerging markets. The landscape of TB diagnostics has changed dramatically during the past ten years. Moreover, in response to the WHO Global TB program, it has implemented a systematic and dynamic process used to evaluate technologies and develop policies, which has enhanced the market's growth.

The prevalence rate of tuberculosis is also increasing every year, along with the number of government awareness programs that influence people to opt for diagnostic tests (like radiographic tests), which are expected to drive the market during the forecast period. The market is also expected to witness growth as there is an opportunity for players in the market to accelerate their pipeline diagnostic products' market approval by spurring the fundamental research in TB. Additionally, technological developments in genomics and proteomics can be leveraged by diagnostic providers to hasten product development in TB diagnostics.

The increasing screening rate in the high burden regions, affordability of diagnostics, advanced methodologies, faster clinical decisions, and reduction in mortality rate are the focal areas of development. Improved preventive and curative diagnosis rates are the results of these initiatives. This has led to a subsequent upsurge in demand for diagnostic tests and the TB diagnostics market. Furthermore, the government and independent healthcare organizations have undertaken initiatives to control this infectious disease's proliferation. Creating awareness about the importance of diagnosis is vital in increasing the screening and diagnosis rates, further helping the TB diagnostics market flourish. This factor is driving the growth of the market in the forecast period. For instance, the Revised National Tuberculosis Control Program (RNTCP) in India focuses on performing TB screening and providing greater access to treatment through free diagnosis & treatment programs. Besides, private-public partnerships under this program are boosting the diagnosis rate.

Population above the age of 60 is the target population for the TB diagnostics market as this demographic is susceptible to infectious diseases. The growing geriatric population base, as a result, is driving the growth of the market.

Drug resistance with tuberculosis drugs is expected to hamper the market growth.

However, drug resistance in tuberculosis is one of the primary concerns for healthcare professionals as improper treatment due to wrong drug regimens and incorrect dosage forms lead to drug resistance in TB patients undergoing treatment, restraining the market's growth.

Industry Analysis

The global tuberculosis testing market provides in-depth analysis of the market based on various industry factors such as Porter's Five Forces, Regulatory Analysis, Supply Chain Analysis, Pricing Analysis, Product Innovation, Unmet Needs.

Segment Analysis

Test type segment is expected to hold the largest market share in global Tuberculosis Testing market

The global tuberculosis testing market is segmented on test type by Cytokine Detection Assay, Nuclеic Acid Tеsting, Detection of Latent Infection, Culturе Basеd Tеsts, Drug Suscеptibility Tеsting, and Othеrs. The Nuclеic Acid Tеsting segment held the largest market share due to its use as diagnostic tools for tuberculosis (TB) for many years, and which continue to be used. There are substantial advancements in the diagnosis of TB. Moreover, these tests have been commercially available in the United States for over two decades that offer better accuracy than other microscopy tests and even provide greater speed than culture-based tests. A nucleic acid test for tuberculosis (TB) is a molecular test used to detect the DNA (deoxyribonucleic acid) of Mycobacterium tuberculosis complex (MTBC) in sputum or other respiratory samples. Because the amount of DNA in a sample is minimal, NAA testing includes a step that amplifies (or copies) the genetic material. Polymerase Chain Reaction (PCR) is a common form of nucleic acid test used in laboratory diagnosis. Drug Suscеptibility Tеsting is expected to have positive market growth because they are cost-efficient and easy-to-perform. The high burden regions rely on these methodologies due to their financial and technical incapability to incorporate advanced technologies, thus contributing to its growth.

A Cytokine Detection Assay is usually employed to check for the specific cytokines being secreted. This is more a function of biochemistry research rather than a specific test for body functions. Cytokines and their receptors are under a great deal of research because of their role in disease control. It is worth noting that many cytokines have an opposing and sometimes complementary effect on each other; thereby, modulating the immune response's severity. Cytokine assays are used to identify which cytokines and their deficiencies are responsible for the cause of some autoimmune diseases.

A Detection of Latent Infection The goal of testing for LTBI is to identify individuals at increased risk for developing tuberculosis (TB) and, therefore, who would benefit from treatment of latent TB infection. Only those who would benefit from treatment should be tested, so a decision to test presupposes a decision to treat if the test is positive. This factor would drive the growth of the market in the forecast period.

Geographical Analysis

North America region holds the largest market share in the global tuberculosis testing market

By region, the Tuberculosis Testing market is segmented into North America, South America, Europe, Asia-Pacific, Middle-East, and Africa. Asia-Pacific dominated the global tuberculosis testing market and is expected to grow at the highest CAGR during the forecast period. The growth of the market in the region is attributed to tuberculosis's high burden and the rapid proliferation of this disease. The increasing prevalence of TB in Japan helps in the TB diagnostics market's growth. The high prevalence of TB creates an urgent demand for effective and quick diagnosis of the disease. Besides, in countries such as India, according to the recent budget announcement, the Government of India aims to eliminate tuberculosis by 2025, which is expected to act as one of the major factors for the growth of the Asia-Pacific market forecast period.

Infectious and Endemic Disease Control in China, RNTCP in India, and the National TB program in Afghanistan are the few programs planned by local healthcare agencies to contain the incidence and ensure equitable access to diagnosis. As per the WHO, countries such as India, China, Afghanistan, and Indonesia are priority regions for controlling this communicable disease.

Competitive Landscape

The global tuberculosis testing market is highly competitive, with the presence of several international and local markets. Product diversification, revenue generation, and opportunities intensify the market competition. Thermo Fisher Scientific, Inc., Hologic Corporation, Abbott Laboratories, Alere, Inc., Becton, Dickinson and Company, F. Hoffmann-La Roche AG, bioMerieux SA, Sanofi, Cepheid, Hain Lifescience GmbH, are the leading market players with significant market share.

Key Companies to Watch

Abbott Laboratories:

Overview: Abbott is American multinational company that develops medical devices and healthcare products. It was founded in 1888 and is headquartered in Illinois, United States. Their products and services include medical devices, diagnostics, nutritional products and branded generic medicines.

Product Portfolio:

The Abbott RealTime MTB assay is an in vitro polymerase chain reaction (PCR) assay for the qualitative detection of MTB complex DNA in smear positive or smear negative specimen of sputum or bronchial alveolar lavage and N-acetyl-L-cysteine (NALC)-prepared sediments prepared from sputum and broncial alveolar lavage collected from individuals suspected of having tuberculosis (TB).

The global tuberculosis testing market report would provide an access to an approx. 45+market data table, 40+figures and 180pages.

Table of Contents

1. Global Tuberculosis Testing Market Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Global Tuberculosis Testing Market - Market Definition and Overview

3. Global Tuberculosis Testing Market- Executive Summary

• 3.1. Market Snippet by Test Type
• 3.2. Market Snippet by End User
• 3.3. Market Snippet by Region

4. Global Tuberculosis Testing Market Dynamics

• 4.1. Market Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. Increasing burden of tuberculosis and multidrug-resistant Tuberculosis
    • 4.1.1.2. Increasing government initiatives and rising awareness in the emerging Market
  • 4.1.2. Restraints
    • 4.1.2.1. High costs associated with tuberculosis diagnostics
    • 4.1.2.2. Resistance to the TB medicines
• 4.2. Impact Analysis
• 4.3. Opportunity

5. Global Tuberculosis Testing Market - Industry Analysis

• 5.1. Porter's Five Forces Analysis
• 5.2. Supply Chain Analysis
• 5.3. Regulatory Analysis
• 5.4. Pricing Analysis
• 5.5. Product Analysis
• 5.6. Industry Value Chain Analysis

6. Global Tuberculosis Testing Market - By Test Type

• 6.1. Introduction
• 6.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Test Type
• 6.3. Market Attractiveness Index, By Test Type
  • 6.3.1. Nuclеic Acid Tеsting*
    • 6.3.1.1. Introduction
    • 6.3.1.2. Market Size Analysis, US$ Mn, 2016-2025 and Y-o-Y Growth Analysis (%), 2019-2027
  • 6.3.2. Cytokine Detection Assay
  • 6.3.3. Detection of Latent Infection
  • 6.3.4. Culturе Basеd Tеsts
  • 6.3.5. Drug Suscеptibility Tеsting
  • 6.3.6. Others

7. Global Tuberculosis Testing Market - By End-User

• 7.1. Introduction
• 7.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
• 7.3. Market Attractiveness Index, By End User
  • 7.3.1. Hospital laboratories*
    • 7.3.1.1. Introduction
    • 7.3.1.2. Market Size Analysis, USD Mn, 2016-2025 and Y-o-Y Growth Analysis (%), 2018-2027
  • 7.3.2. Research laboratories
  • 7.3.3. Clinics laboratories
  • 7.3.4. Diagnostic center

8. Global Tuberculosis Testing Market - By Region

• 8.1. Introduction
• 8.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
• 8.3. Market Attractiveness Index, By Region
• 8.4. North America*
  • 8.4.1. Introduction
  • 8.4.2. Key Region-Specific Dynamics
  • 8.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Test Type
  • 8.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
  • 8.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 8.4.5.1. U.S.
    • 8.4.5.2. Canada
    • 8.4.5.3. Mexico
• 8.5. Europe
  • 8.5.1. Introduction
  • 8.5.2. Key Region-Specific Dynamics
  • 8.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Test Type
  • 8.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
  • 8.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 8.5.5.1. Germany
    • 8.5.5.2. U.K.
    • 8.5.5.3. France
    • 8.5.5.4. Rest of Europe
• 8.6. South America
  • 8.6.1. Introduction
  • 8.6.2. Key Region-Specific Dynamics
  • 8.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Test Type
  • 8.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
  • 8.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 8.6.5.1. Brazil
    • 8.6.5.2. Argentina
    • 8.6.5.3. Rest of South America
• 8.7. Asia Pacific
  • 8.7.1. Introduction
  • 8.7.2. Key Region-Specific Dynamics
  • 8.7.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Test Type
  • 8.7.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
  • 8.7.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 8.7.5.1. China
    • 8.7.5.2. India
    • 8.7.5.3. Japan
    • 8.7.5.4. Australia
    • 8.7.5.5. Rest of Asia Pacific
• 8.8. The Middle East and Africa
  • 8.8.1. Introduction
  • 8.8.2. Key Region-Specific Dynamics
  • 8.8.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Test Type
  • 8.8.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

9. Global Tuberculosis Testing Market Competitive Landscape

• 9.1. Competitive Scenario
• 9.2. Market Positioning/Share Analysis
• 9.3. Mergers and Acquisitions Analysis

10. Global Tuberculosis Testing Market Company Profiles

• 10.1. Thermo Fisher Scientific, Inc. *
  • 10.1.1. Company Overview
  • 10.1.2. Product Portfolio and Description
  • 10.1.3. Key Developments
  • 10.1.4. Financial Overview
• 10.2. Hologic Corporation
• 10.3. Abbott Laboratories
• 10.4. Alere, Inc.
• 10.5. Lupin Pharmaceuticals, Inc.
• 10.6. Becton, Dickinson and Company
• 10.7. F. Hoffmann-La Roche AG
• 10.8. bioMerieux SA
• 10.9. Sanofi.
• 10.10. Cepheid
• List is not exhaustive

11. Global Tuberculosis Testing Market - Premium Insights

12. Global Tuberculosis Testing Market - DataM

• 12.1. Appendix
• 12.2. About Us and Services
• 12.3. Contact Us